Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Compass Pathways navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.
Kindred relates to LPs for $104m fund
Legal & General is among the limited partners for Kindred Capital’s second fund, which also attracted University of Chicago and will invest in early-stage European startups.
MPL scores $90m funding round
Telkom Indonesia and Go-Jek have thrown their weight behind Mobile Premier League’s latest funding round that will allow the esports platform to expand outside of India.
Finch has the guts for $90m series D
SymBiosis and Susquehanna International Group were among a consortium of new and existing backers that supplied $90m in series D financing to Finch Therapeutics.
Shift gears up with $82.5m fund
The Dutch multi-university venture fund had targeted $70m for its latest fund but ended up attracting $82.5m from investors including Protix and Corbion.
Kyee accumulates $64m in series D funding
Tencent has led a $64m series D round for the healthtech developer, whose shareholders already include SoftBank.
Tonal works out $110m round
Evolution Media and new investor Amazon Alexa Fund helped home fitness product developer Tonal hike its overall funding to $200m.
Corporates floor Lava with $83m
Novo Ventures and Sanofi Ventures co-led a series C round for the cancer therapy developer with backing from returning investor MRL Ventures Fund.
Infarm produces $170m for series C
Bonnier contributed to the $170m first close of a the urban farming technology developer’s series C round, taking its debt and equity financing to at least $305m.
Seegrid reframes latest round to $52m
Giant Eagle-backed warehouse vehicle manufacturer Seegrid has more than doubled its latest round to $52m, building on an initial $25m from G2VP six months ago.
Carousell spins $80m round
The e-commerce marketplace secured $80m in a round led by Naver and backed by its Mirae Asset-Naver Asia Growth Fund at a post-money valuation topping $900m.
Acko stacks up $60m in series D
The online insurer took its total valuation to $500m in a round led by Munich Re Ventures and backed by fellow corporate investors Amazon and Intact Financial.
Biocytogen brings in $142m
China Life has returned for a $142m series D-plus round for cancer treatment developer Biocytogen, having already co-led its $77m series D round 13 months ago.